231 related articles for article (PubMed ID: 32341498)
1. Molecular and clinicopathologic characterization of intravenous leiomyomatosis.
Ordulu Z; Chai H; Peng G; McDonald AG; De Nictolis M; Garcia-Fernandez E; Hardisson D; Prat J; Li P; Hui P; Oliva E; Buza N
Mod Pathol; 2020 Sep; 33(9):1844-1860. PubMed ID: 32341498
[TBL] [Abstract][Full Text] [Related]
2. Recurrent chromosomal aberrations in intravenous leiomyomatosis of the uterus: high-resolution array comparative genomic hybridization study.
Buza N; Xu F; Wu W; Carr RJ; Li P; Hui P
Hum Pathol; 2014 Sep; 45(9):1885-92. PubMed ID: 25033729
[TBL] [Abstract][Full Text] [Related]
3. MED12 exon 2 mutation is uncommon in intravenous leiomyomatosis: clinicopathologic features and molecular study.
Wang L; Hu S; Xin F; Zhao H; Li G; Ran W; Xing X; Wang J
Hum Pathol; 2020 May; 99():36-42. PubMed ID: 32240666
[TBL] [Abstract][Full Text] [Related]
4. Identification of the molecular relationship between intravenous leiomyomatosis and uterine myoma using RNA sequencing.
Zhang X; Wu L; Xu R; Zhu C; Ma G; Zhang C; Liu X; Zhao H; Miao Q
Sci Rep; 2019 Feb; 9(1):1442. PubMed ID: 30723247
[TBL] [Abstract][Full Text] [Related]
5. Detailed Morphologic and Immunohistochemical Characterization of Myomectomy and Hysterectomy Specimens From Women With Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC).
Chan E; Rabban JT; Mak J; Zaloudek C; Garg K
Am J Surg Pathol; 2019 Sep; 43(9):1170-1179. PubMed ID: 31162287
[TBL] [Abstract][Full Text] [Related]
6. Intravenous leiomyomatosis is inclined to a solid entity different from uterine leiomyoma based on RNA-seq analysis with RT-qPCR validation.
Wang W; Wang Y; Chen F; Zhang M; Jia R; Liu X; Zhang C; Shao J; Cheng N; Ma G; Zhu Z; Miao Q; Liang Z
Cancer Med; 2020 Jul; 9(13):4581-4592. PubMed ID: 32372565
[TBL] [Abstract][Full Text] [Related]
7. Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors.
Ordulu Z; Nucci MR; Dal Cin P; Hollowell ML; Otis CN; Hornick JL; Park PJ; Kim TM; Quade BJ; Morton CC
Mod Pathol; 2016 May; 29(5):500-10. PubMed ID: 26892441
[TBL] [Abstract][Full Text] [Related]
8. Intravenous leiomyomatosis of the uterus: A clinicopathologic analysis of 13 cases with an emphasis on histogenesis.
Tang L; Lu B
Pathol Res Pract; 2018 Jun; 214(6):871-875. PubMed ID: 29699902
[TBL] [Abstract][Full Text] [Related]
9. Intravenous leiomyomatosis of the uterus. A clinicopathological analysis of 16 cases with unusual histologic features.
Clement PB; Young RH; Scully RE
Am J Surg Pathol; 1988 Dec; 12(12):932-45. PubMed ID: 3202247
[TBL] [Abstract][Full Text] [Related]
10. Intravenous leiomyomatosis: molecular and cytogenetic analysis of a case.
Quade BJ; Dal Cin P; Neskey DM; Weremowicz S; Morton CC
Mod Pathol; 2002 Mar; 15(3):351-6. PubMed ID: 11904348
[TBL] [Abstract][Full Text] [Related]
11. Intravenous leiomyomatosis of the uterus.
Arora R; Abou-Bakr AA; Ahmad MS
Gulf J Oncolog; 2010 Jan; (7):57-9. PubMed ID: 20164011
[TBL] [Abstract][Full Text] [Related]
12. Intravenous leiomyomatosis revisited: an experience of 14 cases at a single medical center.
Carr RJ; Hui P; Buza N
Int J Gynecol Pathol; 2015 Mar; 34(2):169-76. PubMed ID: 25675187
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features and clinical outcomes of intravenous leiomyomatosis of the uterus: A case series.
Yu X; Fu J; Cao T; Huang L; Qie M; Ouyang Y
Medicine (Baltimore); 2021 Jan; 100(1):e24228. PubMed ID: 33429819
[TBL] [Abstract][Full Text] [Related]
14. Two oncomiRs, miR-182-5p and miR-103a-3p, Involved in Intravenous Leiomyomatosis.
Barnaś E; Skręt-Magierło JE; Paszek S; Kaznowska E; Potocka N; Skręt A; Sakowicz A; Zawlik I
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980984
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary benign metastasizing leiomyoma associated with intravenous leiomyomatosis of the uterus: clinical behavior and genomic changes supporting a transportation theory.
Lee HJ; Choi J; Kim KR
Int J Gynecol Pathol; 2008 Jul; 27(3):340-5. PubMed ID: 18580311
[TBL] [Abstract][Full Text] [Related]
16. [Intravenous leiomyomatosis of the uterus].
Banaczek Z; Woźniak M; Grzeszczyk J
Ginekol Pol; 2003 Feb; 74(2):159-61. PubMed ID: 12715427
[TBL] [Abstract][Full Text] [Related]
17. Intravenous leiomyomatosis of the uterus. A report of three cases.
Andrade LA; Torresan RZ; Sales JF; Vicentini R; De Souza GA
Pathol Oncol Res; 1998; 4(1):44-7. PubMed ID: 9555121
[TBL] [Abstract][Full Text] [Related]
18. Leiomyomatosis with vascular invasion. A unified pathogenesis regarding leiomyoma with vascular microinvasion, benign metastasizing leiomyoma and intravenous leiomyomatosis.
Canzonieri V; D'Amore ES; Bartoloni G; Piazza M; Blandamura S; Carbone A
Virchows Arch; 1994; 425(5):541-5. PubMed ID: 7850080
[TBL] [Abstract][Full Text] [Related]
19. Intravenous leiomyomatosis of the uterus with pulmonary metastases or a case with benign metastasizing leiomyoma?
Bodner-Adler B; Bartl M; Wagner G
Anticancer Res; 2009 Feb; 29(2):495-6. PubMed ID: 19331193
[TBL] [Abstract][Full Text] [Related]
20. Hereditary leiomyomatosis and renal cell carcinoma syndrome associated uterine smooth muscle tumors: Bridging morphology and clinical screening.
Garg K; Rabban J
Genes Chromosomes Cancer; 2021 Mar; 60(3):210-216. PubMed ID: 33099845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
